A citation-based method for searching scientific literature

Xuchao Zhang, Zhiyong Liang, Shengyue Wang, Shun Lu, Yong Song, Ying Cheng, Jianming Ying, Weiping Liu, Yingyong Hou, Yangqiu Li, Yi Liu, Jun Hou, Xiufeng Liu, Jianyong Shao, Yanhong Tai, Zheng Wang, Li Fu, Hui Li, Xiaojun Zhou, Hua Bai, Mengzhao Wang, You Lu, Jinji Yang, Wenzhao Zhong, Qing Zhou, Xuening Yang, Jie Wang, Cheng Huang, Xiaoqing Liu, Xiaoyan Zhou, Shirong Zhang, Hongxia Tian, Yu Chen, Ruibao Ren, Ning Liao, Chunyan Wu, Zhongzheng Zhu, Hongming Pan, Yanhong Gu, Liwei Wang, Yunpeng Liu, Suzhan Zhang, Tianshu Liu, Gong Chen, Zhimin Shao, Binghe Xu, Qingyuan Zhang, Ruihua Xu, Lin Shen, Yilong Wu, On Behalf Of Chinese Society Of Clinical Oncology Csco Tumor Biomarker Committee.  2019
Times Cited: 8







List of co-cited articles
5 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The landscape of somatic copy-number alteration across human cancers.
Rameen Beroukhim, Craig H Mermel, Dale Porter, Guo Wei, Soumya Raychaudhuri, Jerry Donovan, Jordi Barretina, Jesse S Boehm, Jennifer Dobson, Mitsuyoshi Urashima,[...]. Nature 2010
25


Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer.
Justin F Gainor, Leila Dardaei, Satoshi Yoda, Luc Friboulet, Ignaty Leshchiner, Ryohei Katayama, Ibiayi Dagogo-Jack, Shirish Gadgeel, Katherine Schultz, Manrose Singh,[...]. Cancer Discov 2016
494
25

Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs.
Mark G Kris, Bruce E Johnson, Lynne D Berry, David J Kwiatkowski, A John Iafrate, Ignacio I Wistuba, Marileila Varella-Garcia, Wilbur A Franklin, Samuel L Aronson, Pei-Fang Su,[...]. JAMA 2014
921
25

Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy.
Y S Li, B Y Jiang, J J Yang, X C Zhang, Z Zhang, J Y Ye, W Z Zhong, H Y Tu, H J Chen, Z Wang,[...]. Ann Oncol 2018
76
25

Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma.
Xiang Chen, Armita Bahrami, Alberto Pappo, John Easton, James Dalton, Erin Hedlund, David Ellison, Sheila Shurtleff, Gang Wu, Lei Wei,[...]. Cell Rep 2014
344
12


Copy number gains in EGFR and copy number losses in PTEN are common events in osteosarcoma tumors.
Serena S Freeman, Steven W Allen, Ramapriya Ganti, Jianrong Wu, Jing Ma, Xiaoping Su, Geoff Neale, Jeffrey S Dome, Najat C Daw, Joseph D Khoury. Cancer 2008
77
12

Prognostic significance of VEGF expression in osteosarcoma: a meta-analysis.
Xiao-Wei Yu, Tian-Yi Wu, Xiang Yi, Wei-Ping Ren, Zu-bin Zhou, Yu-qiang Sun, Chang-qing Zhang. Tumour Biol 2014
44
12

A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma.
S H Friend, R Bernards, S Rogelj, R A Weinberg, J M Rapaport, D M Albert, T P Dryja. Nature 1986
12



COSMIC: exploring the world's knowledge of somatic mutations in human cancer.
Simon A Forbes, David Beare, Prasad Gunasekaran, Kenric Leung, Nidhi Bindal, Harry Boutselakis, Minjie Ding, Sally Bamford, Charlotte Cole, Sari Ward,[...]. Nucleic Acids Res 2015
12

Phase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: a report from the Children's Oncology Group.
Lars M Wagner, Maryam Fouladi, Atif Ahmed, Mark D Krailo, Brenda Weigel, Steven G DuBois, L Austin Doyle, Helen Chen, Susan M Blaney. Pediatr Blood Cancer 2015
67
12

RNA Sequencing and Analysis.
Kimberly R Kukurba, Stephen B Montgomery. Cold Spring Harb Protoc 2015
179
12

Retinoblastoma: clues to human oncogenesis.
A L Murphree, W F Benedict. Science 1984
434
12


Pazopanib in metastatic osteosarcoma: significant clinical response in three consecutive patients.
Akmal Safwat, Anders Boysen, Arne Lücke, Philip Rossen. Acta Oncol 2014
29
12

Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma.
Sam Behjati, Patrick S Tarpey, Kerstin Haase, Hongtao Ye, Matthew D Young, Ludmil B Alexandrov, Sarah J Farndon, Grace Collord, David C Wedge, Inigo Martincorena,[...]. Nat Commun 2017
89
12

RNA-Seq: a revolutionary tool for transcriptomics.
Zhong Wang, Mark Gerstein, Michael Snyder. Nat Rev Genet 2009
12

OncoKB: A Precision Oncology Knowledge Base.
Debyani Chakravarty, Jianjiong Gao, Sarah M Phillips, Ritika Kundra, Hongxin Zhang, Jiaojiao Wang, Julia E Rudolph, Rona Yaeger, Tara Soumerai, Moriah H Nissan,[...]. JCO Precis Oncol 2017
569
12

Anti-angiogenic therapy for osteosarcoma.
Gerald M Y Quan, Peter F M Choong. Cancer Metastasis Rev 2006
40
12

Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-b as Involved in the Pathogenesis of Osteosarcoma.
Rui Yang, Sajida Piperdi, Yue Zhang, Zhu Zhu, Neophytos Neophytou, Bang H Hoang, Gary Mason, David Geller, Howard Dorfman, Paul A Meyers,[...]. Clin Orthop Relat Res 2016
13
12

Targeting CDK4/6 in patients with cancer.
Erika Hamilton, Jeffrey R Infante. Cancer Treat Rev 2016
162
12

Whole-exome sequencing in osteosarcoma reveals important heterogeneity of genetic alterations.
M Bousquet, C Noirot, F Accadbled, J Sales de Gauzy, M P Castex, P Brousset, A Gomez-Brouchet. Ann Oncol 2016
53
12

Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma.
Jennifer A Perry, Adam Kiezun, Peter Tonzi, Eliezer M Van Allen, Scott L Carter, Sylvan C Baca, Glenn S Cowley, Ami S Bhatt, Esther Rheinbay, Chandra Sekhar Pedamallu,[...]. Proc Natl Acad Sci U S A 2014
228
12

Mutational landscape and significance across 12 major cancer types.
Cyriac Kandoth, Michael D McLellan, Fabio Vandin, Kai Ye, Beifang Niu, Charles Lu, Mingchao Xie, Qunyuan Zhang, Joshua F McMichael, Matthew A Wyczalkowski,[...]. Nature 2013
12

Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma.
Lara E Davis, Vanessa Bolejack, Christopher W Ryan, Kristen N Ganjoo, Elizabeth T Loggers, Sant Chawla, Mark Agulnik, Michael B Livingston, Damon Reed, Vicky Keedy,[...]. J Clin Oncol 2019
54
12

Advances in understanding cancer genomes through second-generation sequencing.
Matthew Meyerson, Stacey Gabriel, Gad Getz. Nat Rev Genet 2010
724
12

Whole transcriptome analysis identifies differentially regulated networks between osteosarcoma and normal bone samples.
Xuan Dung Ho, Phuong Phung, Van Q Le, Van H Nguyen, Ene Reimann, Ele Prans, Gea Kõks, Katre Maasalu, Nghi Tn Le, Le H Trinh,[...]. Exp Biol Med (Maywood) 2017
25
12

Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma.
J F McIntyre, B Smith-Sorensen, S H Friend, J Kassell, A L Borresen, Y X Yan, C Russo, J Sato, N Barbier, J Miser. J Clin Oncol 1994
156
12

TP53 intron 1 hotspot rearrangements are specific to sporadic osteosarcoma and can cause Li-Fraumeni syndrome.
Sebastian Ribi, Daniel Baumhoer, Kristy Lee, Edison, Audrey S M Teo, Babita Madan, Kang Zhang, Wendy K Kohlmann, Fei Yao, Wah Heng Lee,[...]. Oncotarget 2015
42
12

Genetically engineered mouse models and human osteosarcoma.
Alvin Jm Ng, Anthony J Mutsaers, Emma K Baker, Carl R Walkley. Clin Sarcoma Res 2012
27
12

Advances in limb salvage treatment of osteosarcoma.
Yichun Yang, Lei Han, Zewei He, Xiaojuan Li, Suping Yang, Jifei Yang, Ya Zhang, Dongqi Li, Yihaho Yang, Zuozhang Yang. J Bone Oncol 2017
41
12


The impact of osteoblastic differentiation on osteosarcomagenesis in the mouse.
T Quist, H Jin, J-F Zhu, K Smith-Fry, M R Capecchi, K B Jones. Oncogene 2015
27
12

Prognostic Values of CCNE1 Amplification and Overexpression in Cancer Patients: A Systematic Review and Meta-analysis.
Haiyue Zhao, Junling Wang, Yong Zhang, Ming Yuan, Shuangxiang Yang, Lisong Li, Huilin Yang. J Cancer 2018
10
12

Theranostic Profiling for Actionable Aberrations in Advanced High Risk Osteosarcoma with Aggressive Biology Reveals High Molecular Diversity: The Human Fingerprint Hypothesis.
Daniela Egas-Bejar, Pete M Anderson, Rishi Agarwal, Fernando Corrales-Medina, Eswaran Devarajan, Winston W Huh, Robert E Brown, Vivek Subbiah. Oncoscience 2014
37
12

mTOR signaling in growth control and disease.
Mathieu Laplante, David M Sabatini. Cell 2012
12

Cyclin E1 is amplified and overexpressed in osteosarcoma.
William W Lockwood, Deirdre Stack, Thomas Morris, David Grehan, Conor O'Keane, Greg L Stewart, Joanna Cumiskey, Wan L Lam, Jeremy A Squire, David M Thomas,[...]. J Mol Diagn 2011
37
12

Expression and therapeutic implications of cyclin-dependent kinase 4 (CDK4) in osteosarcoma.
Yubing Zhou, Jacson K Shen, Zujiang Yu, Francis J Hornicek, Quancheng Kan, Zhenfeng Duan. Biochim Biophys Acta Mol Basis Dis 2018
17
12

Screening of diagnostic markers for osteosarcoma.
Dajiang Wu, Kai Chen, Yushu Bai, Xiaodong Zhu, Ziqiang Chen, Chuanfeng Wang, Yingchuan Zhao, Ming Li. Mol Med Rep 2014
22
12

Genetic and clonal dissection of osteosarcoma progression and lung metastasis.
Huaiyuan Xu, Xiaojun Zhu, Hua Bao, Tony Wh Shek, Zongwen Huang, Yongqian Wang, Xue Wu, Yong Wu, Zhili Chang, Shuyu Wu,[...]. Int J Cancer 2018
17
12

Genomic sequencing in cancer.
Musaffe Tuna, Christopher I Amos. Cancer Lett 2013
13
12

Prevention of postoperative progression of pulmonary metastases in osteosarcoma by antiangiogenic therapy using endostatin.
Mitsunori Kaya, Takuro Wada, Satoshi Nagoya, Toshihiko Yamashita. J Orthop Sci 2007
28
12

Dynamic analysis of lung metastasis by mouse osteosarcoma LM8: VEGF is a candidate for anti-metastasis therapy.
Takaaki Tanaka, Yoshihiro Yui, Norifumi Naka, Toru Wakamatsu, Kiyoko Yoshioka, Nobuhito Araki, Hideki Yoshikawa, Kazuyuki Itoh. Clin Exp Metastasis 2013
21
12

Phase II study of the mammalian target of rapamycin inhibitor ridaforolimus in patients with advanced bone and soft tissue sarcomas.
Sant P Chawla, Arthur P Staddon, Laurence H Baker, Scott M Schuetze, Anthony W Tolcher, Gina Z D'Amato, Jean-Yves Blay, Monica M Mita, Kamalesh K Sankhala, Lori Berk,[...]. J Clin Oncol 2012
171
12

The Gene Expression Omnibus Database.
Emily Clough, Tanya Barrett. Methods Mol Biol 2016
409
12

Molecular pathogenesis of osteosarcoma.
Maya Kansara, David M Thomas. DNA Cell Biol 2007
192
12

Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
Leo Kager, Andreas Zoubek, Ulrike Pötschger, Ulrike Kastner, Silke Flege, Beate Kempf-Bielack, Detlev Branscheid, Rainer Kotz, Mechthild Salzer-Kuntschik, Winfried Winkelmann,[...]. J Clin Oncol 2003
470
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.